146 related articles for article (PubMed ID: 24131787)
1. Impact of cardiac support device combined with slow-release prostacyclin agonist in a canine ischemic cardiomyopathy model.
Kubota Y; Miyagawa S; Fukushima S; Saito A; Watabe H; Daimon T; Sakai Y; Akita T; Sawa Y
J Thorac Cardiovasc Surg; 2014 Mar; 147(3):1081-7. PubMed ID: 24131787
[TBL] [Abstract][Full Text] [Related]
2. A slow-releasing form of prostacyclin agonist (ONO1301SR) enhances endogenous secretion of multiple cardiotherapeutic cytokines and improves cardiac function in a rapid-pacing-induced model of canine heart failure.
Shirasaka T; Miyagawa S; Fukushima S; Saito A; Shiozaki M; Kawaguchi N; Matsuura N; Nakatani S; Sakai Y; Daimon T; Okita Y; Sawa Y
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):413-21. PubMed ID: 23541854
[TBL] [Abstract][Full Text] [Related]
3. Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy: a promising regenerative therapy for the failing heart.
Ishimaru K; Miyagawa S; Fukushima S; Saito A; Sakai Y; Ueno T; Sawa Y
J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1516-25. PubMed ID: 24229503
[TBL] [Abstract][Full Text] [Related]
4. Synthetic prostacycline agonist, ONO-1301, ameliorates left ventricular dysfunction and cardiac fibrosis in cardiomyopathic hamsters.
Hirata Y; Soeki T; Akaike M; Sakai Y; Igarashi T; Sata M
Biomed Pharmacother; 2009 Dec; 63(10):781-6. PubMed ID: 19906506
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable vs Nonbiodegradable Cardiac Support Device for Treating Ischemic Cardiomyopathy in a Canine Heart.
Kitahara M; Miyagawa S; Fukushima S; Saito A; Shintani A; Akita T; Sawa Y
Semin Thorac Cardiovasc Surg; 2017 Spring; 29(1):51-61. PubMed ID: 28683998
[TBL] [Abstract][Full Text] [Related]
6. Local delivery of synthetic prostacycline agonist augments collateral growth and improves cardiac function in a swine chronic cardiac ischemia model.
Iwata H; Nakamura K; Sumi M; Ninomiya M; Sakai Y; Hirata Y; Akaike M; Igarashi T; Takamoto S; Nagai R; Sata M
Life Sci; 2009 Jul; 85(5-6):255-61. PubMed ID: 19527738
[TBL] [Abstract][Full Text] [Related]
7. A prostacyclin agonist and an omental flap increased myocardial blood flow in a porcine chronic ischemia model.
Yajima S; Miyagawa S; Fukushima S; Sakai Y; Isohashi K; Watabe T; Ikeda H; Horitsugi G; Harada A; Sakaniwa R; Hatazawa J; Sawa Y
J Thorac Cardiovasc Surg; 2018 Jul; 156(1):229-241.e14. PubMed ID: 29627179
[TBL] [Abstract][Full Text] [Related]
8. Bovine model of chronic ischemic cardiomyopathy: implications for ventricular assist device research.
Bartoli CR; Sherwood LC; Giridharan GA; Slaughter MS; Wead WB; Prabhu SD; Koenig SC
Artif Organs; 2013 Dec; 37(12):E202-14. PubMed ID: 23876076
[TBL] [Abstract][Full Text] [Related]
9. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K
J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
[TBL] [Abstract][Full Text] [Related]
10. Changes in natriuretic peptides following passive containment surgery in heart failure patients with dilated cardiomyopathy.
Bredin F; Liska J; Franco-Cereceda A
Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):191-4. PubMed ID: 19008326
[TBL] [Abstract][Full Text] [Related]
11. Cardiac structure and function improvements in coronary artery disease combined with severe obstructive sleep apnea/hypopnea syndrome patients via noninvasive positive pressure ventilation therapy.
Liu X; Feng L; Cao G; Huang H; Xu Q; Yu J; Zhang S; Zhou M
Coron Artery Dis; 2014 Sep; 25(6):516-20. PubMed ID: 24870115
[TBL] [Abstract][Full Text] [Related]
12. Effects of omapatrilat on cardiac nerve sprouting and structural remodeling in experimental congestive heart failure.
Cha YM; Redfield MM; Shah S; Shen WK; Fishbein MC; Chen PS
Heart Rhythm; 2005 Sep; 2(9):984-90. PubMed ID: 16171755
[TBL] [Abstract][Full Text] [Related]
13. Intramyocardial injection of heart tissue-derived extracellular matrix improves postinfarction cardiac function in rats.
Dai W; Gerczuk P; Zhang Y; Smith L; Kopyov O; Kay GL; Jyrala AJ; Kloner RA
J Cardiovasc Pharmacol Ther; 2013 May; 18(3):270-9. PubMed ID: 23345062
[TBL] [Abstract][Full Text] [Related]
14. Canine nonischemic left ventricular dysfunction: a model of chronic human cardiomyopathy.
Nishijima Y; Feldman DS; Bonagura JD; Ozkanlar Y; Jenkins PJ; Lacombe VA; Abraham WT; Hamlin RL; Carnes CA
J Card Fail; 2005 Oct; 11(8):638-44. PubMed ID: 16230269
[TBL] [Abstract][Full Text] [Related]
15. Association of myocardial fibrosis, B-type natriuretic peptide, and cardiac magnetic resonance parameters of remodeling in chronic ischemic cardiomyopathy.
Henkel DM; Glockner J; Miller WL
Am J Cardiol; 2012 Feb; 109(3):390-4. PubMed ID: 22078219
[TBL] [Abstract][Full Text] [Related]
16. Myocardial size and fibrosis changes during left ventricular assist device support.
Yamada Y; Saito S; Nishinaka T; Yamazaki K
ASAIO J; 2012; 58(4):402-6. PubMed ID: 22739784
[TBL] [Abstract][Full Text] [Related]
17. Carvedilol may alleviate late cardiac remodelling following surgical ventricular restoration.
Yoshikawa E; Marui A; Tsukashita M; Nishina T; Wang J; Muranaka H; Ikeda T; Komeda M
Eur J Cardiothorac Surg; 2010 Feb; 37(2):362-7. PubMed ID: 19692266
[TBL] [Abstract][Full Text] [Related]
18. Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on left ventricular remodeling in non-obstructive hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene.
Magga J; Sipola P; Vuolteenaho O; Risteli J; Jääskeläinen P; Peuhkurinen K; Kuusisto J
Am J Cardiol; 2008 Apr; 101(8):1185-90. PubMed ID: 18394456
[TBL] [Abstract][Full Text] [Related]
19. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
[TBL] [Abstract][Full Text] [Related]
20. The effect of cardiac fibrosis on left ventricular remodeling, diastolic function, and N-terminal pro-B-type natriuretic peptide levels in patients with nonischemic dilated cardiomyopathy.
Karaahmet T; Tigen K; Dundar C; Pala S; Guler A; Kilicgedik A; Cevik C; Mahmutyazicioglu K; Isiklar I; Basaran Y
Echocardiography; 2010 Sep; 27(8):954-60. PubMed ID: 20849483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
